{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T12:22:24Z","timestamp":1769948544188,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"DOI":"10.7759\/cureus.91559","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:21:20Z","timestamp":1756945280000},"source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Safety of Ormeloxifene Versus Conventional Hormonal Therapy in Women With Non-structural Abnormal Uterine Bleeding: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Sruthy P","family":"Sulaiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poomalar","family":"Gunasekaran Kala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reenaa","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dr. Jenifer","family":"F Mary J","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preethi","family":"Tamilarasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suja","family":"Xaviar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011457","article-title":"Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age: a cross-sectional study","volume":"97","author":"Sun Y","year":"2018","unstructured":"Sun Y, Wang Y, Mao L, Wen J, Bai W. Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age: a cross-sectional study. Medicine (Baltimore). 2018, 97:e11457. 10.1097\/MD.0000000000011457","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58111503","article-title":"Evaluation of the safety and efficacy of ormeloxifene, a selective estrogen receptor modulator and medroxyprogesterone acetate in women with non-structural abnormal uterine bleeding: a randomized clinical trial","volume":"58","author":"Mir SA","year":"2022","unstructured":"Mir SA, Ara R, Amin F, et al.. Evaluation of the safety and efficacy of ormeloxifene, a selective estrogen receptor modulator and medroxyprogesterone acetate in women with non-structural abnormal uterine bleeding: a randomized clinical trial. Medicina (Kaunas). 2022, 58:1503. 10.3390\/medicina58111503","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00168.x","article-title":"A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding","volume":"10","author":"Liu Z","year":"2007","unstructured":"Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health. 2007, 10:183-94. 10.1111\/j.1524-4733.2007.00168.x","journal-title":"Value Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2005.14.316","article-title":"Menstrual-related problems and psychological distress among women in the United States","volume":"14","author":"Strine TW","year":"2005","unstructured":"Strine TW, Chapman DP, Ahluwalia IB. Menstrual-related problems and psychological distress among women in the United States. J Womens Health (Larchmt). 2005, 14:316-23. 10.1089\/jwh.2005.14.316","journal-title":"J Womens Health (Larchmt)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro MG","year":"2011","unstructured":"Munro MG, Critchley HO, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011, 113:3-13. 10.1016\/j.ijgo.2010.11.011","journal-title":"Int J Gynaecol Obstet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-2011.2012.00178.x","article-title":"Abnormal uterine bleeding during the reproductive years","volume":"57","author":"Davidson BR","year":"2012","unstructured":"Davidson BR, Dipiero CM, Govoni KD, Littleton SS, Neal JL. Abnormal uterine bleeding during the reproductive years. J Midwifery Womens Health. 2012, 57:248-54. 10.1111\/j.1542-2011.2012.00178.x","journal-title":"J Midwifery Womens Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21276\/obgyn.2021.8.1.20","article-title":"Clinical spectrum and causes of abnormal uterine bleeding in reproductive age according to two FIGO systems","volume":"8","author":"Singh PB","year":"2021","unstructured":"Singh PB, Purwar R, Mall RP. Clinical spectrum and causes of abnormal uterine bleeding in reproductive age according to two FIGO systems . New Indian J OBGYN. 2021, 8:105-11. 10.21276\/obgyn.2021.8.1.20","journal-title":"New Indian J OBGYN"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20183762","article-title":"Dysfunctional uterine bleeding: ormeloxifene versus combined oral contraceptive pills","volume":"7","author":"Luthra S","year":"2018","unstructured":"Luthra S, Dwivedi AD. Dysfunctional uterine bleeding: ormeloxifene versus combined oral contraceptive pills. Int J Reprod Contracept Obstet Gynecol. 2018, 7:3610-4. 10.18203\/2320-1770.ijrcog20183762","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.25.14105","article-title":"Molecular determinants of tissue selectivity in estrogen receptor modulators","volume":"94","author":"Grese TA","year":"1997","unstructured":"Grese TA, Sluka JP, Bryant HU, et al.. Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc Natl Acad Sci U S A. 1997, 94:14105-10. 10.1073\/pnas.94.25.14105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5958\/2394-2754.2016.00051.5","article-title":"Ormeloxifene- a new treatment modality in dysfunctional uterine bleeding: efficacy and safety","volume":"3","author":"Karmakar S","year":"2016","unstructured":"Karmakar S, Deshpande H. Ormeloxifene- a new treatment modality in dysfunctional uterine bleeding: efficacy and safety. Indian J Obstet Gynecol Res. 2016, 3:225-8. 10.5958\/2394-2754.2016.00051.5","journal-title":"Indian J Obstet Gynecol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18535\/jmscr\/v8i1.21","article-title":"Efficacy and safety of ormeloxifene versus low dose OCP in the treatment of abnormal uterine bleeding (AUB)","volume":"8","author":"Sinha S","year":"2020","unstructured":"Sinha S, Regmi M C, Pradhan T. Efficacy and safety of ormeloxifene versus low dose OCP in the treatment of abnormal uterine bleeding (AUB). J Med Sci Clin Res . 2020, 8:157-63. 10.18535\/jmscr\/v8i1.21","journal-title":"J Med Sci Clin Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1586\/17474108.4.2.179","article-title":"Health-related quality of life and economic burden of abnormal uterine bleeding","volume":"4","author":"Fraser IS","year":"2009","unstructured":"Fraser IS, Langham S, Uhl-Hochgraeber K. Health-related quality of life and economic burden of abnormal uterine bleeding. Exp Rev Obstet Gynecol. 2009, 4:179-89. 10.1586\/17474108.4.2.179","journal-title":"Exp Rev Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2008.00987.x","article-title":"Efficacy and safety of ormeloxifene in management of menorrhagia: a pilot study","volume":"35","author":"Kriplani A","year":"2009","unstructured":"Kriplani A, Kulshrestha V, Agarwal N. Efficacy and safety of ormeloxifene in management of menorrhagia: a pilot study. J Obstet Gynaecol Res. 2009, 35:746-52. 10.1111\/j.1447-0756.2008.00987.x","journal-title":"J Obstet Gynaecol Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2013\/6396.3602","article-title":"A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding","volume":"7","author":"Ravibabu K","year":"2013","unstructured":"Ravibabu K, Palla J, Chintada GS. A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding. J Clin Diagn Res. 2013, 7:2534-6. 10.7860\/JCDR\/2013\/6396.3602","journal-title":"J Clin Diagn Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/med.1011","article-title":"Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders","volume":"21","author":"Singh MM","year":"2001","unstructured":"Singh MM. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Med Res Rev. 2001, 21:302-47. 10.1002\/med.1011","journal-title":"Med Res Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5455\/njppp.2021.11.10285202024102020","article-title":"Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding. A prospective interventional quasi-randomized interval clinical study","volume":"11","author":"Arathy R","year":"2021","unstructured":"Arathy R, Pillai S, Sreedevi N S, et al.. Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding. A prospective interventional quasi-randomized interval clinical study. Natl J Physiol Pharm Pharmacol. 2021, 11:246-52. 10.5455\/njppp.2021.11.10285202024102020","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20195343","article-title":"Ormeloxifene versus combined oral contraceptive pills to control blood loss in cases of dysfunctional uterine bleeding","volume":"8","author":"Gupta A","year":"2019","unstructured":"Gupta A, Raj R. Ormeloxifene versus combined oral contraceptive pills to control blood loss in cases of dysfunctional uterine bleeding. Int J Reprod Contracept Obstet Gynecol . 2019, 8:4909-14. 10.18203\/2320-1770.ijrcog20195343","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref18","article-title":"Ormeloxifen HCL vs combined oral contraceptive pill in treatment of DUB","volume":"3","author":"Khare V","year":"2014","unstructured":"Khare V, Ghosh G, Patil P, et al.. Ormeloxifen HCL vs combined oral contraceptive pill in treatment of DUB. J Evol Med Dent Sci. 2014, 3:1026-33.","journal-title":"J Evol Med Dent Sci"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.4103\/2278-344X.143056","article-title":"Comparative study of low-dose oral contraceptive pill and ormeloxifene in the treatment of dysfunctional uterine bleeding","volume":"3","author":"Mandal D","year":"2014","unstructured":"Mandal D, Parmanik S, Surana S, et al.. Comparative study of low-dose oral contraceptive pill and ormeloxifene in the treatment of dysfunctional uterine bleeding.  Int J Health Allied Sci. 2014, 3:225-31.","journal-title":"Int J Health Allied Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20212964","article-title":"Comparative study of ormeloxifene and low dose oral contraceptive pill for the treatment of dysfunctional uterine bleeding in peri-menopausal age group","volume":"10","author":"Shah M","year":"2021","unstructured":"Shah M, Parmar C, Gor R. Comparative study of ormeloxifene and low dose oral contraceptive pill for the treatment of dysfunctional uterine bleeding in peri-menopausal age group. Int J Reprod Contracept Obstet Gynecol . 2021, 10:3112-8. 10.18203\/2320-1770.ijrcog20212964","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2217\/whe.15.87","article-title":"Hysterectomy for heavy menstrual bleeding","volume":"12","author":"van der Meij E","year":"2016","unstructured":"van der Meij E, Emanuel MH. Hysterectomy for heavy menstrual bleeding. Womens Health (Lond). 2016, 12:63-9. 10.2217\/whe.15.87","journal-title":"Womens Health (Lond)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1991.tb13484.x","article-title":"Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice records","volume":"98","author":"Coulter A","year":"1991","unstructured":"Coulter A, Bradlow J, Agass M, Martin-Bates C, Tulloch A. Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice records. Br J Obstet Gynaecol. 1991, 98:789-96. 10.1111\/j.1471-0528.1991.tb13484.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.2.7214","article-title":"Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy","volume":"86","author":"Alexandersen P","year":"2001","unstructured":"Alexandersen P, Riis BJ, Stakkestad JA, Delmas PD, Christiansen C. Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy. J Clin Endocrinol Metab. 2001, 86:755-60. 10.1210\/jcem.86.2.7214","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/jmh.JMH_71_16","article-title":"Ormeloxifene - looking beyond contraception","volume":"8","author":"Pati T","year":"2017","unstructured":"Pati T, Chanania K, Marandi S, Hansa J. Ormeloxifene - looking beyond contraception. J Midlife Health. 2017, 8:17-20. 10.4103\/jmh.JMH_71_16","journal-title":"J Midlife Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/337461-efficacy-and-safety-of-ormeloxifene-versus-conventional-hormonal-therapy-in-women-with-non-structural-abnormal-uterine-bleeding-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:21:26Z","timestamp":1756945286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/337461-efficacy-and-safety-of-ormeloxifene-versus-conventional-hormonal-therapy-in-women-with-non-structural-abnormal-uterine-bleeding-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.91559","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}